Prevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice | Publicación